HEADER LYASE 15-JAN-14 4CLT TITLE CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH ADENOSINE-3', TITLE 2 5'-CYCLIC-MONOPHOSPHATE AND PYROPHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 1-469; COMPND 5 SYNONYM: AH-RELATED PROTEIN, ADENYLATE CYCLASE HOMOLOG, GERM CELL COMPND 6 SOLUBLE ADENYLYL CYCLASE, HSAC, SAC, TESTICULAR SOLUBLE ADENYLYL COMPND 7 CYCLASE, SOLUBLE ADENYLYL CYCLASE; COMPND 8 EC: 4.6.1.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVL1392 KEYWDS LYASE EXPDTA X-RAY DIFFRACTION AUTHOR S.KLEINBOELTING,M.WEYAND,C.STEEGBORN REVDAT 4 20-DEC-23 4CLT 1 REMARK LINK REVDAT 3 03-APR-19 4CLT 1 SOURCE LINK REVDAT 2 26-MAR-14 4CLT 1 JRNL REVDAT 1 05-MAR-14 4CLT 0 JRNL AUTH S.KLEINBOELTING,A.DIAZ,S.MONIOT,J.VAN DEN HEUVEL,M.WEYAND, JRNL AUTH 2 L.R.LEVIN,J.BUCK,C.STEEGBORN JRNL TITL CRYSTAL STRUCTURES OF HUMAN SOLUBLE ADENYLYL CYCLASE REVEAL JRNL TITL 2 MECHANISMS OF CATALYSIS AND OF ITS ACTIVATION THROUGH JRNL TITL 3 BICARBONATE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 111 3727 2014 JRNL REFN ISSN 0027-8424 JRNL PMID 24567411 JRNL DOI 10.1073/PNAS.132277811 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 87.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 38932 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2065 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2898 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2580 REMARK 3 BIN FREE R VALUE SET COUNT : 133 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3658 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 106 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.27000 REMARK 3 B22 (A**2) : 0.27000 REMARK 3 B33 (A**2) : -0.88000 REMARK 3 B12 (A**2) : 0.13000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.139 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.137 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.100 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.280 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3825 ; 0.020 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3624 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5191 ; 2.063 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8351 ; 0.943 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 466 ; 6.305 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 168 ;35.217 ;24.583 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 650 ;16.031 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;14.529 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 575 ; 0.129 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4256 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 879 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1852 ; 2.618 ; 2.275 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1851 ; 2.606 ; 2.274 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2313 ; 4.014 ; 3.390 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1973 ; 4.050 ; 2.844 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 469 REMARK 3 ORIGIN FOR THE GROUP (A): 22.2796 25.7032 0.7765 REMARK 3 T TENSOR REMARK 3 T11: 0.0064 T22: 0.0330 REMARK 3 T33: 0.0262 T12: 0.0074 REMARK 3 T13: 0.0084 T23: 0.0057 REMARK 3 L TENSOR REMARK 3 L11: 0.5421 L22: 0.4622 REMARK 3 L33: 0.7254 L12: 0.0512 REMARK 3 L13: 0.1657 L23: -0.0458 REMARK 3 S TENSOR REMARK 3 S11: -0.0077 S12: -0.0039 S13: 0.0174 REMARK 3 S21: 0.0079 S22: 0.0020 S23: 0.0908 REMARK 3 S31: -0.0064 S32: -0.1319 S33: 0.0057 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED REMARK 4 REMARK 4 4CLT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1290059443. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918409 REMARK 200 MONOCHROMATOR : SI111-DCM WITH SAGITTAL BENDER REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40997 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 87.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.63000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 4CLF REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE PH 4.8, 0.2 M TRI REMARK 280 -SODIUM-CITRATE, 15% (W/V) PEG 4000, 10% (V/V) GLYCEROL, PH 6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.60500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.60500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.60500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -104.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 50.48500 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 87.44259 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 -0.866025 0.000000 100.97000 REMARK 350 BIOMT2 3 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 131 REMARK 465 THR A 132 REMARK 465 GLN A 133 REMARK 465 GLU A 134 REMARK 465 TRP A 135 REMARK 465 GLU A 136 REMARK 465 GLU A 137 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 HIS A 475 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 139 CG CD1 CD2 REMARK 470 LYS A 340 CG CD CE NZ REMARK 470 GLU A 353 CG CD OE1 OE2 REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 468 CG CD CE NZ REMARK 470 VAL A 469 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 80 CB SER A 80 OG -0.085 REMARK 500 SER A 264 CB SER A 264 OG -0.084 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 159 CB - CG - OD1 ANGL. DEV. = 6.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 10 57.39 -98.11 REMARK 500 HIS A 28 55.77 35.13 REMARK 500 ASP A 65 19.51 57.68 REMARK 500 ASP A 159 -161.30 -120.70 REMARK 500 ASN A 216 -60.33 -92.34 REMARK 500 ASP A 258 97.65 -174.06 REMARK 500 GLN A 329 36.50 73.26 REMARK 500 PHE A 338 145.20 -179.28 REMARK 500 ASP A 357 17.87 52.32 REMARK 500 LYS A 378 -6.42 86.51 REMARK 500 ASP A 455 106.54 -163.37 REMARK 500 ARG A 465 -82.18 -67.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 355 PRO A 356 148.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1471 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 47 OD1 REMARK 620 2 ASP A 99 OD1 95.1 REMARK 620 3 POP A1474 O4 145.3 85.7 REMARK 620 4 POP A1474 O3 80.2 153.8 84.0 REMARK 620 N 1 2 3 REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1471 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CMP A 1472 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CMP A 1473 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE POP A 1474 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1475 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1476 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CLF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE (APO FORM) REMARK 900 RELATED ID: 4CLK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH REMARK 900 ALPHA,BETA-METHYLENEADENOSINE-5'-TRIPHOSPHATE REMARK 900 RELATED ID: 4CLL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH REMARK 900 BICARBONATE REMARK 900 RELATED ID: 4CLP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE COMPLEX WITH REMARK 900 ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE REMARK 900 RELATED ID: 4CLS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH REMARK 900 PYROPHOSPHATE REMARK 900 RELATED ID: 4CLU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE WITH REMARK 900 PYROPHOSPHATE DBREF 4CLT A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 4CLT HIS A 470 UNP Q96PN6 EXPRESSION TAG SEQADV 4CLT HIS A 471 UNP Q96PN6 EXPRESSION TAG SEQADV 4CLT HIS A 472 UNP Q96PN6 EXPRESSION TAG SEQADV 4CLT HIS A 473 UNP Q96PN6 EXPRESSION TAG SEQADV 4CLT HIS A 474 UNP Q96PN6 EXPRESSION TAG SEQADV 4CLT HIS A 475 UNP Q96PN6 EXPRESSION TAG SEQRES 1 A 475 MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO ILE SEQRES 2 A 475 VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL TYR SEQRES 3 A 475 GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR PHE SEQRES 4 A 475 ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE THR SEQRES 5 A 475 ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET ASP SEQRES 6 A 475 ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR HIS SEQRES 7 A 475 ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY GLY SEQRES 8 A 475 ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA LEU SEQRES 9 A 475 TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE THR SEQRES 10 A 475 VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU PHE SEQRES 11 A 475 GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG VAL SEQRES 12 A 475 LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU VAL SEQRES 13 A 475 PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE GLY SEQRES 14 A 475 GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET ALA SEQRES 15 A 475 GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP GLN SEQRES 16 A 475 LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL PRO SEQRES 17 A 475 ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO PRO SEQRES 18 A 475 PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS THR SEQRES 19 A 475 THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS ASN SEQRES 20 A 475 LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO GLU SEQRES 21 A 475 LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER ILE SEQRES 22 A 475 LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR LEU SEQRES 23 A 475 SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN LEU SEQRES 24 A 475 MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY PRO SEQRES 25 A 475 ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL LEU SEQRES 26 A 475 LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET PHE SEQRES 27 A 475 ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE PRO SEQRES 28 A 475 GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU GLU SEQRES 29 A 475 CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL HIS SEQRES 30 A 475 LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY ILE SEQRES 31 A 475 VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS GLU SEQRES 32 A 475 TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA ARG SEQRES 33 A 475 MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SER SEQRES 34 A 475 VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE PHE SEQRES 35 A 475 LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA ASP SEQRES 36 A 475 SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU LYS SEQRES 37 A 475 VAL HIS HIS HIS HIS HIS HIS MODRES 4CLT CME A 253 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 253 10 HET MG A1471 1 HET CMP A1472 22 HET CMP A1473 22 HET POP A1474 9 HET CL A1475 1 HET EDO A1476 4 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM MG MAGNESIUM ION HETNAM CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE HETNAM POP PYROPHOSPHATE 2- HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN CMP CYCLIC AMP; CAMP HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 MG MG 2+ FORMUL 3 CMP 2(C10 H12 N5 O6 P) FORMUL 5 POP H2 O7 P2 2- FORMUL 6 CL CL 1- FORMUL 7 EDO C2 H6 O2 FORMUL 8 HOH *106(H2 O) HELIX 1 MET A 1 ALA A 18 0 18 HELIX 2 MET A 1 TYR A 26 0 26 HELIX 3 MET A 1 SER A 59 0 59 HELIX 4 MET A 1 PHE A 89 0 89 HELIX 5 MET A 1 PHE A 130 0 130 HELIX 6 MET A 1 ALA A 182 0 175 HELIX 7 MET A 1 CYS A 197 0 190 HELIX 8 MET A 1 THR A 235 0 228 HELIX 9 MET A 1 LYS A 246 0 239 HELIX 10 MET A 1 LYS A 267 0 260 HELIX 11 MET A 1 ASP A 278 0 271 HELIX 12 MET A 1 PHE A 328 0 321 HELIX 13 MET A 1 GLN A 375 0 368 HELIX 14 MET A 1 TYR A 421 0 414 HELIX 15 MET A 1 SER A 435 0 428 SHEET 1 AA 5 ASP A 92 ALA A 97 0 SHEET 2 AA 5 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AA 5 PHE A 35 SER A 49 -1 O VAL A 42 N TRP A 105 SHEET 4 AA 5 ARG A 142 GLY A 158 -1 O ARG A 142 N SER A 49 SHEET 5 AA 5 SER A 163 ILE A 168 1 O HIS A 164 N PHE A 157 SHEET 1 AB 7 ASP A 92 ALA A 97 0 SHEET 2 AB 7 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AB 7 PHE A 35 SER A 49 -1 O VAL A 42 N TRP A 105 SHEET 4 AB 7 ARG A 142 GLY A 158 -1 O ARG A 142 N SER A 49 SHEET 5 AB 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AB 7 VAL A 213 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AB 7 ILE A 202 SER A 206 -1 O GLU A 203 N ASN A 216 SHEET 1 AC 2 SER A 163 ILE A 168 0 SHEET 2 AC 2 ARG A 142 GLY A 158 1 O SER A 153 N ILE A 168 SHEET 1 AD 5 GLY A 330 MET A 337 0 SHEET 2 AD 5 GLY A 341 PHE A 348 -1 O SER A 343 N PHE A 336 SHEET 3 AD 5 GLU A 288 MET A 300 -1 O THR A 293 N PHE A 348 SHEET 4 AD 5 THR A 381 HIS A 398 -1 O THR A 381 N MET A 300 SHEET 5 AD 5 ARG A 401 ILE A 407 1 O ARG A 401 N HIS A 398 SHEET 1 AE 7 GLY A 330 MET A 337 0 SHEET 2 AE 7 GLY A 341 PHE A 348 -1 O SER A 343 N PHE A 336 SHEET 3 AE 7 GLU A 288 MET A 300 -1 O THR A 293 N PHE A 348 SHEET 4 AE 7 THR A 381 HIS A 398 -1 O THR A 381 N MET A 300 SHEET 5 AE 7 VAL A 425 CYS A 427 1 O THR A 426 N VAL A 386 SHEET 6 AE 7 TYR A 460 TYR A 462 -1 O TYR A 460 N CYS A 427 SHEET 7 AE 7 PHE A 442 GLU A 444 -1 O LYS A 443 N GLN A 461 SHEET 1 AF 2 ARG A 401 ILE A 407 0 SHEET 2 AF 2 THR A 381 HIS A 398 1 O PHE A 392 N ILE A 407 LINK C ALA A 252 N CME A 253 1555 1555 1.33 LINK C CME A 253 N THR A 254 1555 1555 1.34 LINK OD1 ASP A 47 MG MG A1471 1555 1555 2.45 LINK OD1 ASP A 99 MG MG A1471 1555 1555 2.25 LINK MG MG A1471 O4 POP A1474 1555 1555 2.12 LINK MG MG A1471 O3 POP A1474 1555 1555 2.63 CISPEP 1 ARG A 33 PRO A 34 0 4.55 SITE 1 AC1 4 ASP A 47 ILE A 48 ASP A 99 POP A1474 SITE 1 AC2 10 ARG A 199 ILE A 202 GLU A 203 ILE A 204 SITE 2 AC2 10 GLU A 205 SER A 206 SER A 323 LYS A 326 SITE 3 AC2 10 ILE A 327 GLN A 329 SITE 1 AC3 12 ALA A 97 GLY A 98 ARG A 176 PHE A 336 SITE 2 AC3 12 LEU A 345 THR A 405 VAL A 406 VAL A 411 SITE 3 AC3 12 ASN A 412 ARG A 416 HOH A2091 HOH A2097 SITE 1 AC4 8 ASP A 47 SER A 49 GLY A 50 PHE A 51 SITE 2 AC4 8 THR A 52 ASP A 99 LYS A 144 MG A1471 SITE 1 AC5 4 LYS A 95 LEU A 166 VAL A 167 HOH A2057 SITE 1 AC6 3 LEU A 255 LYS A 256 ASP A 258 CRYST1 100.970 100.970 97.210 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009904 0.005718 0.000000 0.00000 SCALE2 0.000000 0.011436 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010287 0.00000